Clinical effectiveness of triple drug therapy combination containing laba, lama and ics in non-smoking copd patients- a prospective study over a period of 12 weeks

Abstract

INTRODUCTION Chronic obstructive pulmonary disease (COPD) is a significant global health issue, characterized by persistent respiratory symptoms, including dyspnoea, cough, sputum production, and recurrent lower respiratory tract infections. These symptoms degrade the quality of life and precipitate acute exacerbations leading to hospitalizations. A unique subgroup, nonsmoker-COPD (NS-COPD), is defined by the absence of tobacco smoke exposure but includes other environmental or internal illnesses contributing to COPD. This study aims to evaluate the clinical effectiveness of triple therapy (LABA, LAMA, ICS) in managing NS-COPD. OBJECTIVE To evaluate the clinical effectiveness of triple drug therapy combination containing LABA, LAMA and ICS in non-smoking COPD patients